<DOC>
	<DOCNO>NCT00226655</DOCNO>
	<brief_summary>The purpose study examine long-term safety tolerability human corticotropin-releasing factor ( hCRF ) , XERECEPT® , patient require dexamethasone ( Decadron ) treat peritumoral brain edema . This open-label , extended-use study open patient participate either blinded study , NTI 0302 , NTI 0303 , designate study , include patient may discontinue blind study medication early complete protocol-stipulated follow-up period .</brief_summary>
	<brief_title>An Open-Labeled , Extended-Use XERECEPT ( hCRF ) Patients Studies NTI 0302 , 0303 , Other Designated Studies</brief_title>
	<detailed_description>XERECEPT® potential treatment cancer , may reduce edema associate tumor result , decrease neurological symptom .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Brain Edema</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Corticotropin-Releasing Hormone</mesh_term>
	<criteria>Participation completion stipulate final followup period study NTI 0302 , NTI 0303 , designate study . Have Karnofsky Performance &gt; 50 Baseline Capable selfadministration subcutaneous injection twice daily availability assistance caregiver . Ability provide write informed consent , unable provide , legal guardian representative provide write informed consent . For woman childbearing potential : negative serum pregnancy test Baseline Concurrent enrollment investigational drug device study , NTI 0302 , NTI 0303 , designate study . Systemic steroid use indication peritumoral brain edema . Use intend use dexamethasone antiemetic study . Clinical sign symptom cerebral herniation . Serious concomitant cardiovascular , pulmonary , renal , gastrointestinal endocrine metabolic disease could put patient unusual risk study participation . Confounding previous concurrent neurological disorder would interfere adequate clinical evaluation . Clinically significant head injury chronic seizure disorder , condition result functional impairment likely interfere evaluation . ( Maintenance anticonvulsant therapy allow ) Central nervous system ( CNS ) infection . Pregnancy , breastfeed and/or refusal practice birth control study , woman childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>peritumoral brain edema</keyword>
	<keyword>edema</keyword>
	<keyword>malignant brain tumor</keyword>
	<keyword>astrocytoma</keyword>
	<keyword>brain tumor</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>Decadron</keyword>
</DOC>